Literature DB >> 10161097

Critical aspects of the function of inspiratory flow driven inhalers.

B Olsson1, L Asking.   

Abstract

Powder inhalers rely on the patient's inspiratory flow for delivery and aerosolization of the medicament. Different inhalers offer different resistances to inspiration through the device. The flow rate attained by a patient depends on the effort expended and on the air flow resistance of the device; flow rate is thus a device-dependent variable. A comparison between powder inhalers should therefore take their air flow resistances into account. An empirical relation between the peak inspiratory flow rate through a device and the flow resistance of the device has been developed using results from healthy subjects and verified to a limited extent using data from asthmatic patients. The flow resistance was measured as the pressure drop at a fixed flow rate. The empirical relation can be used to predict the change in peak inspiratory flow rate resulting from a change in flow resistance. Matching flow rates, representing equal inspiratory efforts, may thus be calculated for different inhalation devices.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 10161097     DOI: 10.1089/jam.1994.7.suppl_1.s-43

Source DB:  PubMed          Journal:  J Aerosol Med        ISSN: 0894-2684


  3 in total

1.  Investigation of dry powder inhaler (DPI) resistance and aerosol dispersion timing on emitted aerosol aerodynamic particle sizing by multistage cascade impactor when sampled volume is reduced from compendial value of 4 L.

Authors:  Hlack Mohammed; Jan Arp; Frank Chambers; Mark Copley; Volker Glaab; Mark Hammond; Derek Solomon; Kerry Bradford; Theresa Russell; Yvonne Sizer; Steven C Nichols; Daryl L Roberts; Christopher Shelton; Roland Greguletz; Jolyon P Mitchell
Journal:  AAPS PharmSciTech       Date:  2014-05-29       Impact factor: 3.246

Review 2.  Antiasthma drug delivery. What is on the horizon?

Authors:  J C Virchow; C Kroegel; H Matthys
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

3.  Evaluation of in vitro and in vivo flow rate dependency of budesonide/formoterol Easyhaler(®).

Authors:  L Pekka Malmberg; Mark L Everard; Jussi Haikarainen; Satu Lähelmä
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-06-30       Impact factor: 2.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.